Skip to content
Altius – Lifestyle
Author:
Tangram Therapeutics PLC
Arthur J. Gallagher & Co. Announces First Quarter 2026 Financial Results
May 12, 2026
Tangram Therapeutics Announces First Participant Dosed in Phase 1/2 RESTORE-MASH Trial of TGM-312, a Novel Investigational RNAi Medicine
March 5, 2026